BCR abnormalities in B‐CLL cells include low to undetectable levels of monoclonal surface immunoglobulins, a reduced expression of CD79b, and a malfunction in the downstream pathway, which is predicated by the constitutive activation of both the Lyn and Syk kinases 12, 13. The gene discussed is BCR; the disease is B-cell chronic lymphocytic leukemia.